SATURDAY, MAY 6, 2017

AGENDA

The 2017 Cardiology Update agenda is available via LINK.

 

EVALUATION

The 2017 Cardiology Update program evaluation is available via LINK.

Specific presentation evaluations are located below.

 

Plenary Session | Panel Discussion

Advances in Heart Failure Therapy: So Many Drugs with So Many Options

Dr. Jonathan Howlett

Evaluation | Handout Material

Learning Objectives: Review of contemporary pharmacotherapy for heart failure. Review role of Entresto as an outpatient therapy. Learn about the upcoming studies for treating heart failure.

 

Long‐term Oral Antithrombotic Therapy for Coronary Artery Disease:
Unravelling the Complexity of Treatment

Dr. Robert Welsh & Dr. Wayne Tymchak | Moderator: Dr. Kevin Bainey

Evaluation | Handout Material

Learning Objectives: Understand the duration of dual antiplatelet for CAD (shorter versus longer). Understand the duration of dual antiplatelet for ACS (shorter versus longer). Understand the limitations of triple therapy and the role of a dual antithrombotic approach.

 

How Low Should We Be Targeting LDL for CAD?

Dr. Gabor Gyenes & Dr. Glen Pearson

Evaluation | Handout Material

Learning Objectives: Understanding the rationale for ‘lower the LDL the better’. Evaluating the choice of agents to lower LDL. Reviewing the latest evidence for PCSK9 agents.

 

Stump the Cardiologists: Open Debate Between Common Cardiology Cases

Dr. Brian Sonnenberg & Dr. Bibiana Cujec

Evaluation | Handout Material (1) | Handout Material (2)

Learning Objectives: Understand the selection of transcatheter aortic valve replacement versus surgical aortic valve replacement. Understand the use of NOACS versus warfarin for atrial fibrillation.

 

 

Case Study Workshops

Real Heart Failure Patients

Dr. Jonathan Howlett

Evaluation | Handout Material

Learning Objectives: Gain an understanding of complex heart failure patients. Learn the need for adjunctive therapies. Understand the benefits of Heart Failure clinics and referral.

 

DAPT and Triple Therapy - Case Presentations

Dr. Robert Welsh & Dr. Wayne Tymchak

Evaluation | Handout Material (1) | Handout Material (2)

Learning Objectives: Gain an understanding of shortened versus prolonged DAPT in selected patients. Understand the hazards of triple therapy. Gain further insight into novel approaches to balance thrombotic and bleeding risk.

 

The SPRINT to Treat Hypertension – Is there HOPE?

Dr. Ahmed Abulhamayel

Evaluation | Handout Material

Learning Objectives: Compare and contrast the SPRINT Trial with HOPE 3 Trial. How does new data affect our practice? Which patients fall into such trials? What precautions to take if we follow the new CHEP guidelines in cases sBP <120?

 

Which Medications are Best for Diabetics with CV Disease?

Dr. Errol Raff

Evaluation | Handout Material

Learning Objectives: Compare and contrast the Leader Trial with Empa‐Reg, and Sustain‐6 Trials. Review the CV benefits through unknown different mechanisms.

 

Challenges with Hyperlipidemia

Dr. Gabor Gyenes & Dr. Glen Pearson

Evaluation | Handout Material

Learning Objectives: Gain an appreciation of PCSK9 inhibitors. Understand the benefits of long‐term lower LDL. Understand the safety of lower LDL levels.

 

Patients Best Served with Minimally Invasive Heart Surgery

Dr. Jeevan Nagendran

Evaluation | Handout Material

Learning Objectives: Understand the benefits of minimally invasive heart surgery. Gain an appreciation of referral for minimally invasive heart surgery.

 

Complex Patients with Complex Atrial Fibrillation

Dr. Kenneth Quadros

Evaluation | Handout Material

Learning Objectives: Learn the options for DOACS, Understand the benefits/risks in specialty populations. Review the evidence in CKD patients.

 

Patients with Acute Coronary Syndromes to Follow Closely

Dr. Rahul Potluri

Evaluation |   Handout Material

Learning Objectives: Understand the spectrum of risk in ACS (STEMI versus NSTEMI/UA.  Review secondary preventative therapies – importance and duration, Appreciate the recurrent risk of CV events following ACS in Alberta.

 

© CARDIOLOGY UPDATE. ALL RIGHTS RESERVED.